← Back to catalogue

ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 2

EUDAMED

Class IIa (EU MDR)

Ref 4006-2Model ULTRAMED ENDOTRACHEAL TUBE ORAL/NASALModel ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 2

by Ultra For Medical Products (Ultramed) U.M.I.C (S.A.E)

Identity

Trade Name
ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 2 EUDAMED
Device Name
ULTRAMED ENDOTRACHEAL TUBE EUDAMED
ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED EUDAMED
Model / Reference
ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL EUDAMED
4006-2 EUDAMED
ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 2 EUDAMED

Identifiers

Primary DI / UDI-DI
06223004252327 EUDAMED
Basic UDI-DI
622300425ETT4005WV EUDAMED
B-06223004252327 EUDAMED
EMDN Code
R01030201 ENDOTRACHEAL TUBES, CUFFED, NOT REINFORCED EUDAMED

Classification

Device Class
Class IIa EUDAMED
Market of Registration
Bulgaria EUDAMED

Clinical & Handling

Sterile

Yes

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Category: Basic endotracheal tube, single-use

ULTRAMED ENDOTRACHEAL TUBE ORAL/NASAL CUFFED Size 2 by Ultra For Medical Products (Ultramed) U.M.I.C (S.A.E) — Class IIa — MDD, MDR — listed in EUDAMED

Similar devices

Also classified as Basic endotracheal tube, single-use.

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDD

European Union Active

CE/MDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
EG-MF-000038562
Authorised Representative
Obelis s.a. BE-AR-000000106

Sources (2)

  • EUDAMED 3920f9bd-791f-4004-9ede-dcd826fb2ffb 61 fields · synced Oct 6, 2026
  • EUDAMED 39fb0abb-50a8-4483-abd4-5da8cbc69cf2 61 fields · synced May 17, 2026